BEIGENE, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 154.1 USD | +0.36% |
|
+19.38% | -13.33% |
| 04-23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| 04-23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 159.23 | 159.23 | 170.00 |
| Spread/Res. | -1.83% | -1.83% | -8.05% |
| Spread/Supp. | +20.68% | +20.68% | +20.68% |
| Support | 129.52 | 129.52 | 129.52 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
